In addition, cancer has been identified as a personal factor of COVID-19, so the significance of TMPRSS2 expression in pan-cancers is more likely to be connected to the susceptibility of SARS-CoV-2 to tumor patients (Kuderer et al., 2020; Moris et al., 2020). The gene discussed is TMPRSS2; the disease is neoplasm.